SCHEMBL7459945

SCHEMBL7459945

CC(C)(O)CNC(=O)c1ncccc1C(N)=O

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.48
ALDH1A1 P00352 2/20 0.48
HPGD P15428 2/20 0.48
HSD17B10 Q99714 1/20 0.48
PDE10A Q9Y233 4/20 0.47
SMN1; SMN2 Q16637 4/20 0.44
MAPT P10636 2/20 0.44
RAB9A P51151 2/20 0.44
NPC1 O15118 1/20 0.44
AHR P35869 1/20 0.44
P2RX7 Q99572 1/20 0.43
NAMPT P43490 1/20 0.42
PARP1 P09874 1/20 0.41
CFTR P13569 3/20 0.41
ADORA2B P29275 1/20 0.41
EGLN2 Q96KS0 1/20 0.40
FTO Q9C0B1 1/20 0.40
HTT P42858 1/20 0.40
LMNA P02545 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7459949 0.83 CFTR (0.48) PDE10ANAMPTCFTRADORA2BEGLN2
SCHEMBL7452205 0.82 KDM4E (0.52) KDM4EALDH1A1HPGDHSD17B10SMN1; SMN2
SCHEMBL9213267 0.80 KDM4E (0.61) KDM4EALDH1A1HPGDHSD17B10SMN1; SMN2
SCHEMBL9210564 0.79 KDM4E (0.46) KDM4EALDH1A1HPGDHSD17B10SMN1; SMN2
SCHEMBL28284512 0.78 ALDH1A1 (0.67) KDM4EALDH1A1HPGDHSD17B10SMN1; SMN2
SCHEMBL15402857 0.78 KDM4E (0.48) KDM4EALDH1A1HPGDHSD17B10PDE10A
SCHEMBL15402166 0.78 CFTR (0.43) PDE10AP2RX7PARP1CFTRADORA2B
SCHEMBL9206936 0.78 HTT (0.56) KDM4EALDH1A1HPGDHSD17B10SMN1; SMN2
SCHEMBL15401439 0.78 ALDH1A1 (0.48) KDM4EALDH1A1HPGDHSD17B10PDE10A
SCHEMBL26856707 0.78 PDE10A (0.50) ALDH1A1PDE10ASMN1; SMN2MAPTNAMPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2580207-B1 NITROGEN CONTAINING HETEROARYL COMPOUNDS HOFFMANN LA ROCHE (CH) 2017-09-27 EP claimed
US-8703768-B2 Nitrogen containing heteroaryl compounds HOFFMANN-LA ROCHE INC. (US) 2014-04-22 US claimed
US-8623866-B2 2014-01-07 US claimed
US-20110306589-A1 NITROGEN CONTAINING HETEROARYL COMPOUNDS F. HOFFMANN-LA ROCHE AG (CH) 2011-12-15 US claimed
EP-2580207-B1 NITROGEN CONTAINING HETEROARYL COMPOUNDS HOFFMANN LA ROCHE (CH) 2017-09-27 EP disclosed
US-8703768-B2 Nitrogen containing heteroaryl compounds HOFFMANN-LA ROCHE INC. (US) 2014-04-22 US disclosed
US-8623866-B2 2014-01-07 US disclosed
EP-2580207-A1 NITROGEN CONTAINING HETEROARYL COMPOUNDS F. Hoffmann-La Roche AG (CH) 2013-04-17 EP disclosed
WO-2011154327-A1 NITROGEN CONTAINING HETEROARYL COMPOUNDS F. HOFFMANN-LA ROCHE AG (CH) 2011-12-15 WO disclosed
US-20110306589-A1 NITROGEN CONTAINING HETEROARYL COMPOUNDS F. HOFFMANN-LA ROCHE AG (CH) 2011-12-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110306589-A1 NITROGEN CONTAINING HETEROARYL COMPOUNDS PDE10A, PDE3A, PDE2A KDM4E 2322/4885ALDH1A1 271/4885HPGD 603/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.